Civil Plaintiff

J&J gets new trial after $417M verdict in talc case

Johnson & Johnson deserves a new trial after a jury ordered the world’s largest maker of health-care products to pay $417 million to a woman who blamed the company’s iconic Baby Powder for causing her cancer, an appeals court concluded.

Even though there was sufficient evidence to uphold the jury’s finding that J&J improperly failed to warn Eva Echeverria about the health risks of talc-based powder, conflicting evidence about the product’s cancer links warrants another trial, the Los Angeles-based court said. The ruling is good news for J&J, which suffered a string of recent defeats in lawsuits alleging the company knew its talc-based products could cause various types of cancers and put profits over people’s health.


    Leave a Review or Comment

    Your email address will not be published. Required fields are marked *

    Back to top button